GLP-1

Tirzepatide: How It Works, What It's Studied For & Safety

Quick answer

Tirzepatide is a dual GIP and GLP-1 receptor agonist FDA-approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). Clinicians consider it for glycemic control in type 2 diabetes (FDA-approved). Branded products are FDA-approved under labeled indications; compounded variants are dispensed by Wells Pharmacy Network only after a licensed clinician evaluates intake, history, and labs.

Also known as: Mounjaro, Zepbound

How does Tirzepatide work?

Tirzepatide is a single peptide engineered to bind both the GIP and GLP-1 receptors. The dual-incretin engagement is studied for additive glycemic and weight-management effects beyond single-agonist GLP-1s.

What is Tirzepatide studied for?

  • Glycemic control in type 2 diabetes (FDA-approved)
  • Chronic weight management in adults with obesity or overweight with comorbidities (FDA-approved)
  • Cardiovascular and metabolic-comorbidity research (ongoing)

How is Tirzepatide taken?

FDA-approved as a once-weekly subcutaneous injection (Mounjaro, Zepbound). Compounded preparations on this site are not FDA-approved and are not generic equivalents.

Is Tirzepatide FDA-approved? Is it safe?

FDA-approved as a finished drug product when prescribed under its labeled indications. Compounded variants on this site are separate from the branded product and are dispensed only when a clinician determines a compounded preparation is appropriate. GI side effects similar to other GLP-1s. Boxed warning for thyroid C-cell tumors in rodents. Compounded prescription-only preparations are dispensed by Wells Pharmacy Network. Eligibility is decided by a licensed clinician based on intake and labs, not by checkout. Compounded products on this site are not FDA-approved and are not generic equivalents of any branded medication.

In the Regen Therapy catalog

The protocols below are dispensed by Wells Pharmacy Network and contain Tirzepatide. Each one is prescribed only after a clinician evaluation.

What does the research say about Tirzepatide?

SURPASS (diabetes) and SURMOUNT (obesity) trial programs supported the approvals.

Considering Tirzepatide as part of a protocol?

Browse Regen Therapy's catalog or start a clinician evaluation. Every prescription is reviewed by a licensed clinician and dispensed by Wells Pharmacy Network.

Browse the catalog →